Cancer and other diseases linked to two PFAS are costing society billions of dollars over patients’ lifetimes, an impact that policy makers should consider in decisions about how to manage the chemicals, physicians said in a study published Tuesday.
The study examined economic costs, such as medical bills and reduced worker productivity, detailed in previous studies of 13 diseases attributed to exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), the two most-studied chemicals within the huge group of per- and polyfluoroalkyl substances, or PFAS. The paper appeared in the journal Exposure and Health.
The researchers determined Americans’ exposure to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
